ETNB Insider Transactions

Transaction Date
(SEC Report)
Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price() Amount()
2023-09-09 Mansbach Harry H officer: Chief Medical Officer 100,162 F-InKind D 3,821 16.61 63,467.00
2023-09-09 Martins Ryan officer: Chief Financial Officer 54,221 F-InKind D 2,074 16.61 34,449.00
2023-09-09 Le-Nguyen Quoc officer: See Remarks 163,874 F-InKind D 4,958 16.61 82,352.00
2023-08-01 Mansbach Harry H officer: Chief Medical Officer 104,997 F-InKind D 577 15.64 9,024.00
2023-08-17 Mansbach Harry H officer: Chief Medical Officer 103,983 F-InKind D 1,014 15.46 15,676.00
2023-08-17 PALEKAR ROHAN director, officer: Chief Executive Officer 300,950 F-InKind D 4,501 15.46 69,585.00
2023-08-01 Martins Ryan officer: Chief Financial Officer 57,048 F-InKind D 346 15.64 5,411.00
2023-08-17 Martins Ryan officer: Chief Financial Officer 56,295 F-InKind D 753 15.46 11,641.00
2023-08-01 Le-Nguyen Quoc officer: See Remarks 169,846 F-InKind D 577 15.64 9,024.00
2023-08-01 Le-Nguyen Quoc officer: See Remarks 168,832 F-InKind D 1,014 15.46 15,676.00
2023-07-17 LAPORTE KATHLEEN director 12,500 M-Exempt A 12,500 2.64 33,000.00
2023-07-17 LAPORTE KATHLEEN director 12,500 M-Exempt D 12,500 2.64 33,000.00
2023-07-17 LAPORTE KATHLEEN director 0 S-Sale D 12,500 18.80 235,000.00
2023-06-30 Mansbach Harry H officer: Chief Medical Officer 108,456 A-Award A 8,334 0.00 0.00
2023-06-30 Mansbach Harry H officer: Chief Medical Officer 105,574 F-InKind D 2,882 18.95 54,614.00
2023-06-30 Le-Nguyen Quoc officer: See Remarks 173,305 A-Award A 8,334 0.00 0.00
2023-06-30 Le-Nguyen Quoc officer: See Remarks 170,423 F-InKind D 2,882 18.95 54,614.00
2023-06-30 PALEKAR ROHAN director, officer: Chief Executive Officer 321,978 A-Award A 33,334 0.00 0.00
2023-06-30 PALEKAR ROHAN director, officer: Chief Executive Officer 305,451 F-InKind D 16,527 18.95 313,187.00
2023-06-30 Martins Ryan officer: Chief Financial Officer 59,412 A-Award A 5,834 0.00 0.00
2023-06-30 Martins Ryan officer: Chief Financial Officer 57,394 F-InKind D 2,018 18.95 38,241.00
2023-06-05 PALEKAR ROHAN director, officer: Chief Executive Officer 301,978 M-Exempt A 15,000 1.93 28,950.00
2023-06-05 PALEKAR ROHAN director, officer: Chief Executive Officer 286,978 S-Sale D 15,000 20.00 300,000.00
2023-06-05 PALEKAR ROHAN director, officer: Chief Executive Officer 195,231 M-Exempt D 15,000 1.93 28,950.00
2023-06-01 Atkinson Edward Morrow III director 6,250 M-Exempt A 6,250 2.61 16,312.00
2023-06-01 Atkinson Edward Morrow III director 0 S-Sale D 6,250 17.91 111,938.00
2023-06-01 Atkinson Edward Morrow III director 0 M-Exempt D 6,250 2.61 16,312.00
2023-05-09 Le-Nguyen Quoc officer: See Remarks 178,654 M-Exempt A 18,626 3.11 57,927.00
2023-05-09 Le-Nguyen Quoc officer: See Remarks 164,971 S-Sale D 13,683 18.11 247,799.00
2023-05-09 Le-Nguyen Quoc officer: See Remarks 160,028 M-Exempt A 60,945 3.11 189,539.00
2023-05-09 Le-Nguyen Quoc officer: See Remarks 4,063 M-Exempt D 60,945 3.11 189,539.00
2023-05-09 Le-Nguyen Quoc officer: See Remarks 3,312 M-Exempt D 18,626 3.11 57,927.00
2023-04-04 Martins Ryan officer: Chief Financial Officer 53,578 S-Sale D 8,721 14.95 130,379.00
2023-03-31 Martins Ryan officer: Chief Financial Officer 64,893 A-Award A 7,500 0.00 0.00
2023-03-31 Martins Ryan officer: Chief Financial Officer 62,299 F-InKind D 2,594 15.23 39,507.00
2023-03-31 Martins Ryan officer: Chief Financial Officer 59,411 A-Award A 5,833 0.00 0.00
2023-03-31 Martins Ryan officer: Chief Financial Officer 57,393 F-InKind D 2,018 15.23 30,734.00
2023-03-31 PALEKAR ROHAN director, officer: Chief Executive Officer 302,413 A-Award A 33,333 0.00 0.00
2023-03-31 PALEKAR ROHAN director, officer: Chief Executive Officer 286,970 F-InKind D 15,443 15.23 235,197.00
2023-03-31 Mansbach Harry H officer: Chief Medical Officer 103,004 A-Award A 8,333 0.00 0.00
2023-03-31 Mansbach Harry H officer: Chief Medical Officer 100,122 F-InKind D 2,882 15.23 43,893.00
2023-03-31 Le-Nguyen Quoc officer: See Remarks 100,380 A-Award A 3,750 0.00 0.00
2023-03-31 Le-Nguyen Quoc officer: See Remarks 99,512 A-Award A 8,333 0.00 0.00
2023-03-31 Le-Nguyen Quoc officer: See Remarks 99,083 F-InKind D 1,297 15.23 19,753.00
2023-03-31 Le-Nguyen Quoc officer: See Remarks 96,630 F-InKind D 2,882 15.23 43,893.00
2023-03-24 RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner: 11,081,584 P-Purchase A 2,461,538 16.25 39,999,992.00
2022-04-25 Hayden Michael R director 103,978 P-Purchase A 10,000 2.67 26,700.00
2022-04-07 Hayden Michael R director 93,978 P-Purchase A 10,000 3.48 34,750.00
2022-03-30 Hayden Michael R director 83,978 P-Purchase A 6,250 3.62 22,625.00
2023-03-28 Hayden Michael R director 61,538 P-Purchase A 61,538 16.15 993,839.00
2023-03-23 Martins Ryan officer: Chief Financial Officer 53,578 S-Sale D 5,000 16.11 80,550.00
2023-03-23 PALEKAR ROHAN director, officer: Chief Executive Officer 269,080 S-Sale D 15,000 16.00 240,000.00
2023-03-01 Atkinson Edward Morrow III director 20,000 M-Exempt D 10,000 4.44 44,400.00
2023-03-01 Atkinson Edward Morrow III director 10,000 M-Exempt A 10,000 4.44 44,400.00
2023-03-01 Atkinson Edward Morrow III director 0 S-Sale D 10,000 13.60 136,000.00
2023-02-17 Mansbach Harry H officer: Chief Medical Officer 94,671 F-InKind D 2,127 13.97 29,714.00
2023-02-17 Martins Ryan officer: Chief Financial Officer 61,118 F-InKind D 1,750 13.97 24,448.00
2023-02-21 Martins Ryan officer: Chief Financial Officer 58,578 S-Sale D 2,540 13.89 35,281.00
2023-02-17 Le-Nguyen Quoc officer: See Remarks 91,179 F-InKind D 2,140 13.97 29,896.00
2023-02-17 PALEKAR ROHAN director, officer: Chief Executive Officer 284,072 F-InKind D 6,279 13.97 87,718.00
2023-02-09 Altschuler Steven director 27,400 A-Award A 27,400 14.70 402,780.00
2023-02-09 Martins Ryan officer: Chief Financial Officer 110,000 A-Award A 110,000 14.70 1,617,000.00
2023-02-09 Martins Ryan officer: Chief Financial Officer 62,868 A-Award A 30,000 0.00 0.00
2023-02-09 Mansbach Harry H officer: Chief Medical Officer 120,000 A-Award A 120,000 14.70 1,764,000.00
2023-02-09 Mansbach Harry H officer: Chief Medical Officer 96,798 A-Award A 30,000 0.00 0.00
2023-02-09 PALEKAR ROHAN director, officer: Chief Executive Officer 300,000 A-Award A 300,000 14.70 4,410,000.00
2023-02-09 PALEKAR ROHAN director, officer: Chief Executive Officer 290,351 A-Award A 75,000 0.00 0.00
2023-02-09 Zoth Lota S. director 27,400 A-Award A 27,400 14.70 402,780.00
2023-02-09 Le-Nguyen Quoc officer: See Remarks 120,000 A-Award A 120,000 14.70 1,764,000.00
2023-02-09 Le-Nguyen Quoc officer: See Remarks 93,319 A-Award A 30,000 0.00 0.00
2023-02-09 LAPORTE KATHLEEN director 27,400 A-Award A 27,400 14.70 402,780.00
2023-02-09 Grunberg Gregory director, 10 percent owner: 27,400 A-Award A 27,400 14.70 402,780.00
2023-02-09 Hayden Michael R director 27,400 A-Award A 27,400 14.70 402,780.00
2023-02-09 Atkinson Edward Morrow III director 27,400 A-Award A 27,400 14.70 402,780.00
2023-02-09 DiRocco Derek director 27,400 A-Award A 27,400 14.70 402,780.00
2023-02-08 Martins Ryan officer: Chief Financial Officer 32,868 S-Sale D 1,480 14.41 21,327.00
2023-02-05 Mansbach Harry H officer: Chief Medical Officer 66,798 F-InKind D 1,360 13.24 18,006.00
2023-02-05 PALEKAR ROHAN director, officer: Chief Executive Officer 215,351 F-InKind D 4,078 13.24 53,993.00
2023-02-03 Martins Ryan officer: Chief Financial Officer 81,901 M-Exempt D 3,000 3.11 9,330.00
2023-02-03 Martins Ryan officer: Chief Financial Officer 38,960 S-Sale D 3,000 13.11 39,330.00
2023-02-03 Martins Ryan officer: Chief Financial Officer 38,960 M-Exempt A 3,000 3.11 9,330.00
2023-02-03 Martins Ryan officer: Chief Financial Officer 35,368 S-Sale D 592 12.70 7,518.00
2023-02-05 Martins Ryan officer: Chief Financial Officer 34,348 F-InKind D 592 13.24 7,838.00
2023-02-05 Le-Nguyen Quoc officer: See Remarks 63,319 F-InKind D 1,390 13.24 18,404.00
2023-02-01 Martins Ryan officer: Chief Financial Officer 35,960 F-InKind D 408 12.05 4,916.00
2023-02-01 Mansbach Harry H officer: Chief Medical Officer 68,158 F-InKind D 680 12.05 8,194.00
2023-02-01 Le-Nguyen Quoc officer: See Remarks 64,709 F-InKind D 695 12.05 8,375.00
2023-01-03 Martins Ryan officer: Chief Financial Officer 36,368 S-Sale D 5,947 12.51 74,397.00
2022-11-15 Mansbach Harry H officer: Chief Medical Officer 71,951 A-Award A 9,000 0.00 0.00
2022-11-15 Mansbach Harry H officer: Chief Medical Officer 68,838 F-InKind D 3,113 9.79 30,476.00
2022-10-18 RA CAPITAL MANAGEMENT, L.P. director 8,955,410 P-Purchase A 1,172,741 7.65 8,971,469.00
2022-09-28 Le-Nguyen Quoc officer: See Remarks 65,833 A-Award A 8,333 0.00 0.00
2022-09-28 Le-Nguyen Quoc officer: See Remarks 65,404 F-InKind D 1,297 5.79 7,510.00
2022-09-28 Martins Ryan officer: Chief Financial Officer 44,333 A-Award A 5,833 0.00 0.00
2022-09-28 Martins Ryan officer: Chief Financial Officer 42,315 F-InKind D 2,018 5.76 11,624.00
2022-09-28 Mansbach Harry H officer: Chief Medical Officer 65,833 A-Award A 8,333 0.00 0.00
2022-09-28 Mansbach Harry H officer: Chief Medical Officer 62,951 F-InKind D 2,882 5.76 16,600.00
2022-09-28 PALEKAR ROHAN officer: Chief Executive Officer 230,956 A-Award A 33,333 0.00 0.00
2022-09-28 PALEKAR ROHAN officer: Chief Executive Officer 219,429 F-InKind D 11,527 5.76 66,396.00
2022-09-08 PALEKAR ROHAN officer: Chief Executive Officer 197,623 M-Exempt A 100,000 1.93 193,000.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.